Columns - Pharmaceutical Executive

ADVERTISEMENT

Columns

Washington Report: Labels and Liability

March 1, 2006

Pharmaceutical companies are worried that FDA's new labeling format will expose them to liability suits from individuals who suffer adverse events that are not highlighted, but "hidden" in the full prescribing information.

Sales Management: Spending Under Scrutiny

March 1, 2006

Given the high volume of rep interactions with healthcare professionals, companies must work toward achieving a fully integrated system that collects data from across the entire enterprise.

Alternative Media: Masters of Their Domain

March 1, 2006

For years, educational institutions have enjoyed their own Internet domain: .edu. US governmental agencies have .gov, and non-profits have been able to set themselves apart from the crowd with .org in their e-mail and Web addresses. Thanks to changes made to the Internet's Domain Name System (DNS) in 2001, subject-specific vertical segments have been able to flee the .com world for newly established domains, such as .travel, .jobs, .museum, and .info.

Thought Leader: Q&A with Ed Broughton

February 1, 2006

Our co-promotions have helped us build a strong infrastructure in the US.

Backpage: Taking Hold of the Wheel

February 1, 2006

FDA's cautious approach to allowing drug manufacturers to communicate the economic value of drugs is contributing to an already poorly informed healthcare industry, and may be curtailing access to useful drugs.

Medical Education: What Physicians Want

February 1, 2006

Doctors don't want to download a mountain of software, especially if it's not compatible with all computers.

Alternative Media: How to Capture Your target Consumers' Profile Data Online

February 1, 2006

Since each consumer has unique preferences and online habits, marketers should leverage a variety of channels to capture a high volume of targeted consumer profile data, without jeapordizing the quality of their lists.

From the Editor: Terrorism: The Cliff Notes

February 1, 2006

Is the public ready for an exciting thriller about terrorism, drug counterfeiting, valiant FDA agents, and glamorous women who invite pharma CEOs to come up and look at their drug patents? Sure. Maybe someone should write one.

Direct to Consumer: Women are a powerful, but untapped, audience

February 1, 2006

Educational initiatives geared toward women should allow them to interact, so they inspire and empower one another.

ADVERTISEMENT

Click here